Trupanion, Inc. 2016 Form 10-K Summary
Business Context and Reporting Period
Trupanion provides subscription-based medical insurance for cats and dogs in the United States, Canada and Puerto Rico. The filing is an annual report for the fiscal year ended December 31, 2016; fourth-quarter figures are included where relevant. The company operates through subscription and other business segments and had 450 employees at year-end.
Key Financial and Operating Metrics
| Metric | 2016 | 2015 | Change |
|---|---|---|---|
| Total revenue | $188.2 million | $147.0 million | 28% increase |
| Subscription revenue | $173.4 million | $133.4 million | 30% increase |
| Gross profit | $33.3 million | $25.2 million | 32% increase |
| Gross margin | 18% | 17% | Improved |
| Operating loss | $6.7 million | $16.8 million | Improved by $10.1 million |
| Net loss | $6.9 million | $17.2 million | Improved by $10.3 million |
| Adjusted EBITDA | $0.1 million | $(11.3) million | Improved by $11.4 million |
| Operating cash flow | $5.0 million | $(10.4) million | Turned positive |
| Year-end total pets enrolled | 343,649 | 291,818 | 18% increase |
| Year-end subscription pets | 323,233 | 272,636 | 19% increase |
| Average monthly retention | 98.60% | 98.64% | Slight decline |
Subscription business gross profit was $32.0 million, or approximately 18% of subscription revenue. Claims expenses were $133.5 million company-wide, including $124.6 million in the subscription business. Monthly average revenue per pet increased to $47.82 from $45.04, while lifetime value per pet increased to $631 from $591. Average pet acquisition cost declined to $123 from $132, and the reported lifetime-value-to-acquisition-cost ratio increased to 5.1:1 from 4.5:1.
Fourth-quarter 2016 revenue was $51.3 million, gross profit was $9.2 million, net loss was $1.7 million and Adjusted EBITDA was $0.3 million. Fourth-quarter 2015 revenue was $40.2 million, gross profit was $7.3 million, net loss was $3.0 million and Adjusted EBITDA was $(1.6) million.
Liquidity, Capitalization and Cash Flow
- Cash and cash equivalents were $23.6 million and short-term investments were $29.6 million at December 31, 2016; total cash, cash equivalents and restricted cash were $24.2 million.
- Working capital was $34.7 million, compared with $30.0 million at December 31, 2015.
- Total debt was approximately $5.0 million, consisting principally of borrowings under a new $30.0 million revolving credit facility entered into in December 2016. Approximately $21.6 million was available under the facility at year-end.
- The company reported $5.0 million of operating cash flow, $(6.5) million of investing cash flow and $7.7 million of financing cash flow in 2016.
- Management stated that available cash, investments and borrowing capacity were expected to fund operations and statutory capital requirements for at least the next 12 months.
- APIC held $30.5 million of statutory capital and surplus against a $25.8 million required level for the No Action Level. Insurance-company assets are subject to regulatory and dividend restrictions.
- Contractual obligations included $20.7 million of operating lease commitments, $5.5 million of long-term debt obligations, $0.6 million of capital lease obligations and $6.2 million of strategic marketing and service-provider commitments.
Material Changes Versus the Prior Comparable Period
- Revenue growth accelerated modestly to 28% from 27% in 2015, driven by enrollment growth and pricing increases intended to offset higher veterinary costs.
- Subscription enrollment increased 19%, while total enrollment increased 18%.
- Gross margin improved to 18% from 17%, while subscription gross margin remained approximately 18%.
- Operating expenses declined to $40.0 million from $42.0 million. Technology and development expense declined 15% and general and administrative expense declined 2%; sales and marketing expense was essentially flat.
- Operating and net losses narrowed substantially, and Adjusted EBITDA moved slightly positive for the full year.
- Operating cash flow improved by $15.4 million and became positive, primarily due to stronger earnings and growth in claims reserve and deferred revenue.
- Claims reserve increased to $9.5 million from $6.3 million. The company reported that actual 2016 claims exceeded its prior-year reserve estimates by $0.7 million.
- The company replaced its prior credit agreement with a syndicated facility, increasing total facility capacity from $20.0 million to $30.0 million, and borrowed approximately $5.0 million during 2016.
- Canadian revenue represented approximately 20% of total revenue. Foreign exchange movements reduced 2016 Canadian revenue by approximately $1.2 million.
Outlook, Commentary, Risks and Unusual Items
Management intends to continue investing in member acquisition, veterinary referral relationships, technology, Trupanion Express and infrastructure. The filing does not provide a specific numerical revenue or profitability forecast. Management expects technology and general and administrative expenses to decline as a percentage of revenue as the business scales, while continuing to target attractive lifetime value relative to acquisition cost.
- The company has incurred significant cumulative losses, including an accumulated deficit of $81.3 million, and may not achieve or sustain GAAP profitability.
- Claims reserves depend on estimates of frequency, severity, veterinary-cost inflation and incurred-but-not-reported claims. The company retains substantially all insurance risk and does not transfer risk to third-party reinsurers.
- Growth depends heavily on veterinary practices, Territory Partners and other referral sources. Veterinary practices accounted for approximately 71% of enrollments excluding existing-member additions and referrals.
- Insurance regulation may restrict pricing, marketing, licensing, policy forms, capital levels and dividends. APIC’s capital requirements may rise as enrollment grows.
- Canadian operations create foreign-exchange exposure; management estimated that a hypothetical 10% change in the Canadian dollar could affect annual revenue by approximately $3.7 million.
- The business faces competition from self-funded veterinary care, traditional pet insurers and new entrants with greater financial and marketing resources.
- Key operational risks include member retention, acquisition costs, claims administration, technology or cybersecurity failures, privacy compliance, regulatory inquiries, litigation and reliance on third-party service providers.
- The filing identifies legal claims and regulatory proceedings as possible ordinary-course contingencies but does not disclose a specific material pending matter or a clear quantified exposure.
- Subsequent to year-end, the parent company received a $2.7 million dividend from WICL Segregated Account AX, subject to applicable solvency and regulatory restrictions.
- The company reported effective disclosure controls and effective internal control over financial reporting as of December 31, 2016. The audit opinion covered the financial statements but did not express an opinion on internal control over financial reporting.
Most Important Facts for Investors to Verify
- Whether positive operating cash flow and near-breakeven Adjusted EBITDA are sustainable after continued member-acquisition and technology investments.
- Whether claims frequency, severity and veterinary-cost inflation remain consistent with pricing assumptions and whether the $9.5 million claims reserve is adequate.
- Whether retention remains near 98.6% as the member base grows and whether acquisition costs remain below lifetime value.
- APIC’s statutory capital position relative to the $25.8 million requirement and the amount of cash restricted within insurance subsidiaries and trusts.
- Availability, covenant compliance and maturity terms of the $30.0 million revolving credit facility.
- Exposure to Canadian currency movements and the continuation of the Omega fronting and reinsurance arrangements.
- Potential dilution from approximately 4.1 million outstanding stock options, 0.4 million restricted shares or units expected to vest, and 0.8 million warrants.
- The company’s ability to use approximately $79.0 million of federal net operating loss carryforwards, subject to ownership-change limitations and a full valuation allowance.